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Abstract  
In hospital microbial laboratories, morphological and biochemical analyses are performed to identify 
pathogenic microbes ; however, these procedures lack rapidity and accuracy. Recently, Matrix-As-
sisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) has been 
clinically utilized, and is expected to enable rapid and accurate microbial identification. We aimed to 
validate two MALDI-TOF MS devices available in Japan : the VITEK-MS (BioMérieux) and the Mi-
croflex LT (Bruker Daltonics). Clinically isolated bacteria, 100 samples in all, detected in blood cul-
tures but incompletely identified by conventional procedures, were reanalyzed using the two devic-
es. The VITEK-MS and Microflex LT, respectively, identified 49% (49/100) and 80% (80/100) of 
the tested bacteria at the species level, as well as 96% (96/100) and 95% (95/100) at the genus lev-
el. Among those reidentified strains, 26% (26/100) at the species level and 88% (88/100) at the ge-
nus level were concordant with each other, though three strains were unmatched. Moreover, four 
bacterial strains were unable to be identified using the VITEK-MS, versus five using the Microflex 
LT. MALDI-TOF MS devices can provide more rapid and accurate bacterial identification than ever 
before ; however, the characteristics of each system were slightly different ; therefore, it is neces-
sary to understand the difference in performance of  MALDI-TOF MS models.
Key words : MALDI-TOF MS, bloodstream infections
Introduction
Blood culture is among the most important pro-
cedures in clinical microbiology for identifying 
pathogens that cause bloodstream infections 
(BSIs). Rapid and accurate identification of mi-
crobes is beneficial for patients, in that it leads to 
quicker determination of appropriate treatment for 
BSIs1,2). In clinical laboratories, morphological and 
biochemical analyses are typically performed to 
identify such pathogenic microbes, which may be 
distinguished by Gram stain, biochemical properties, 
and colony features such as color, shape, and 
smell. Even in the hands of experienced laboratory 
technicians, these protocols may lack rapidity and 
accuracy.
In recent years, Matrix-Assisted Laser Desorp-
tion/Ionization Time-of-Flight Mass Spectrometry 
(MALDI-TOF MS) has been introduced and utilized 
to identify pathogenic microbes isolated in clinical 
tests such as blood cultures3-5). MALDI-TOF MS 
applies a laser-based ionization technique in which 
large organic molecules are turned into ions, and 
their flight times are analyzed using a mass spec-
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trometer6). The flight time of each ion differs ac-
cording to its mass-to-charge ratio ; therefore, the 
material composition of tested organic material, in-
cluding microbes, can be inferred. Reference spec-
tra aggregated from already-known microbes are ag-
gregated and updated for homological analysis of 
unidentified specimens. When the spectral pattern 
of a sample matches one stored in the database, the 
tested microbe is identified.
In Japan, two types of MALDI-TOF MS devic-
es, the VITEK-MS (BioMérieux, Marcy l’Étoile, 
France) and the Microflex LT (Bruker Daltonics, 
Bremen, Germany), have been approved for use in 
clinical hospital laboratories. Utilizing these two 
models, we reanalyzed clinically isolated pathogenic 
bacteria, 100 sample in all, which had been detected 
in blood cultures, but whose identification failed 
through conventional protocols. In the current 
study, we aimed to validate the MALDI-TOF MS 
devices against conventional protocols, as well as 




Sample bacterial strains were collected via rou-
tine blood cultures, which were ordered by clinicians 
and performed in the clinical microbial laboratory at 
Fukushima Medical University Hospital from Janu-
ary 2013 to December 2015. A total of 106 bacteri-
al strains were nominated for this study, which had 
not been fully identified by conventional proce-
dures. The conventional protocols performed in 
our laboratory include Gram-staining, morphologic 
assessment of colonies, and comparison of their bio-
chemical properties obtained from a MicroScan 
WalkAway System (Beckman Coulter, CA, USA), 
RAPID ID 32 STREP (BioMérieux, Marcy l’Étoile, 
France), and RapID ANA II System (Thermo Fisher 
Scientific, KS, USA). These incompletely identi-
fied bacteria were reported to clinicians based on 
bacterial genus or phenotypic features ; e.g. Staphy-
lococcus sp., Gram-positive chain cocci, Gram-nega-
tive glucose-fermenting rods, etc.
Methods
I) Preservation and re-culturing
The nominated sample bacterial strains were 
preserved at −80°C using Microbank (Pro-Lab Di-
agnostics, Richmond Hill, Canada), a cryo-preserva-
tive vial system for the storage and retrieval of iso-
lated bacterial strains. The strains were re-
cultured on Trypticase Soy Agar with 5% Sheep 
Blood (Becton Dickinson Japan, Tokyo, Japan). In-
cubation procedures varied according to the charac-
teristics of each sample strain. The general or 
noncommittal bacterial strains were aerobically in-
cubated at 35°C for 18 to 24 hours. The anaerobic 
bacterial strains were incubated at 35°C using a 
Thermo Forma Anaerobic System (Thermo Forma, 
Marietta, OH, USA). The strains characterized as 
slow-growing were continuously cultivated at 35°C 
until a sufficient amount was observed. Ultimately, 
6 of the 106 nominated bacterial strains had not 
grown, and 100 bacterial strains which had been re-
cultured were used in this study (Table 1).
II) Instruments and software
The VITEK-MS and Microflex LT, which are 
MALDI-TOF MS devices available in Japan, were 
utilized in this study. Spectral analysis of the ex-
amined 100 sample strains was performed using the 
MALDI Biotyper software version 3.1 (Bruker Dal-
tonics, Bremen, Germany). This software per-
forms matching comparisons of spectral patterns be-
tween the sample bacteria and those from the 
reference databases (libraries) that each manufactur-
er provides and updates.
III) MALDI-TOF analysis
Aliquots of each bacteria, according to manufac-
turers’ instructions, were lifted from the colonies on 
each culture media and gently spotted on the MAL-
DI-TOF examination plate provided by each manu-
facturer. Next, the cell-smear method, a procedure 
to disperse sample bacteria, was performed ; 1-μL 
of alpha-cyano-4-hydroxycinnamic acid matrix solu-
tion (CHCA for VITEK-MS ; BioMérieux, HCCA 
Table 1. Tested Bacterial Strains
Bacterial Strains n
Bacillus spp.  47
Corynebacterium spp.  18
Staphylococcus spp.   8
Streptococcus spp.   5
Peptostreptococcus spp.   1
Gram-positive rods   5
Gram-positive cocci   3
Glucose non-fermenting Gram-negative bacilli  10
Gram-negative rods   1
Anaerobic bacteria   2
Total 100
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for Microflex LT ; Bruker Daltonics) was added to 
each sample plate. After air drying naturally, each 
plate was set into its respective device, and the ana-
lytical procedures were performed, yielding the 
mass spectra of each sample.
Table 2 characterizes the identification reliabili-
ty in each MALDI-TOF MS device. Level 1 Reli-
ability (L1R) means that the bacterial strain is iden-
tified at the species level, where the VITEK-MS 
shows one bacterial species with ≥ 60% reliability, 
or the Microflex LT shows an identification score 
≥ 2.000. When the VITEK-MS shows two to four 
bacterial species, or the Microflex LT shows  a score 
of 1.700 to 1.999, the tested bacterial strain is re-
garded as identified at Level 2 Reliability (L2R), at 
which species identification is unreliable but the ge-
nus is reliable enough. Therefore, even if one bac-
terial species is shown at L2R, the strain is regarded 
as identified at bacterial genus level.
When both MALDI-TOF MS devices were un-
able to identify a sample at L1R or L2R, a reanalysis 
was performed using an additional application, the 
on-plate formic acid extraction method7). Briefly, 
1-μl of formic acid (Wako, Osaka, Japan) was used as 
a cell-smear solution, before adding alpha-cyano-
4-hydroxycinnamic acid matrix solution.
In cases where the identification results dif-
fered between the VITEK-MS and Microflex LT, or 
conflicted with those of conventional protocols, the 
16S ribosomal RNA (rRNA) of the sample bacteria 
were sequenced and each result was confirmed. 
Specifically, DNA was extracted from each strain, 
amplified by PCR using universal primers (27F and 
1492R), and each product was sequenced bidirec-
tionally to determine the nucleotide sequence. 
Then, the homology analysis of each 1,000 to 1,300 
base pairs, including V4 to V6 regions known to be 
beneficial for bacterial identification8), was per-
formed, and each species or genus was identified 
with 98.7% or higher homology. For analysis of the 
16S rRNA sequence, the DNA Data Bank Japan 
(DDBJ), managed by the National Institute of Genet-
ics (Shizuoka, Japan) was referenced.
IV) Calculation and statistical analysis
For the results obtained in this study, the num-
ber of sample strains identified at the species level 
(at L1R), identified at the genus level (at L1R and 
L2R), and unidentified using either MALDI-TOF 
MS device were calculated for the identification 
rates. Concordances of results between the two 
models were also calculated at the species and ge-
nus level, respectively. For the sample strains re-
analyzed using each MALDI-TOF MS device with 
the formic acid extraction method, the results shown 
in the single application and those obtained from re-
analysis were both used for analysis.
The statistical differences between the calculat-
ed results obtained from the two MALDI-TOF MS 
models were compared by applying McNemar’s test, 
including application of Yates’s correction for conti-




The identification rates after each single appli-
cation are shown in Table 3. Using the VITEK-
MS, bacterial species was identified in 47% (47/100) 
at L1R, and genus in 91% (91/100) at L1R and 
L2R ; however, 9% (9/100) remained unidenti-
fied. On the other hand, the identification rates us-
ing the Microflex LT were 71% (71/100) at L1R and 
92% (92/100) at L1R and L2R, with 8% (8/100) re-
Table 2. Identification Reliability Level of VITEK-MS and Microflex LT
Identified Unidentified
Reliability Level of Identification





VITEK-MS Color Indication Green Yellow Red




Microflex LT Color Indication Green Yellow Red
Reliability Score Value ≥ 2.000 1.700-1.999
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maining unidentified. After subsequent analysis 
with the formic acid extraction method, the identifi-
cation rates were partly improved (Table 3). The 
identification rates using the VITEK-MS rose to 
49% (49/100) at L1R and 96% (96/100) at L1R and 
L2R, with 4% (4/100) remaining unidentified. On 
the other hand, a total of 80% (80/100) at L1R and 
95% (95/100) at L1R and L2R were identified using 
the Microflex LT, with 5% (5/100) remaining uniden-
tified. Those data with the formic acid extraction 
method were used for the following analysis.
A comparison with conventional identification 
protocols follows. Of the 79 tested bacterial strains 
with genus-level  identification through conventional 
protocols (47 Bacillus spp., 18 Corynebacterium spp., 
8 Staphylococcus spp., 5 Streptococcus spp., and 1 Pep-
tostreptococcus spp.), 39.2% (31/79) and 86.1% 
(68/79) were resolved to species-level at L1R using 
the VITEK-MS and the Microflex LT, respective-
ly. Furthermore, of the 21 tested strains with nei-
ther genus nor species identification by conventional 
methods, 85.7% (18/21) at L1R and 95.2% (20/21) at 
L1R and L2R with the VITEK-MS were resolved to 
species or genus, respectively, while 57.1% (12/21) 
at L1R and 95.2% (20/21) at L1R and L2R with the 
Microflex LT were resolved to species or genus (Ta-
ble 3).
Regarding bacterial genus, the VITEK-MS 
identified 4.26% (2/47) of Bacillus spp. at the species 
level, while the Microflex LT identified 95.7% 
(45/47) (p<0.001). Moreover, regarding glucose 
non-fermenting Gram-negative rods, the VITEK-
MS identified the species in 100% (10/10), while the 
Microflex LT identified 40% (4/10) at the species 
level (p<0.005). No statistical difference was 
shown between the two MALDI-TOF MS devices in 
the identification rates at species or genus levels for 
bacterial strains other than the aforementioned two 
groups (Table 3).
II) Identification discrepancies between the conven-
tional protocols and MALDI-TOF MS
The respective results of the bacterial identifi-
cation using the two MALDI-TOF MS devices are 
shown in Table 4. Of the sample bacterial strains 
reanalyzed using MALDI-TOF MS devices, 15 bac-
terial strains were identified inconsistently with the 
bacterial species, genus, or morphological features 
indicated through the conventional protocols. That 
is regarded as the identification discrepancy between 
conventional identification protocols and the MAL-
DI-TOF MS devices (indicated by “D” on Table 4), 
calculated as 15% (15/100).
Among these 15 strains, 8 were identified as 
the same bacterial species or genus by both the VI-
TEK-MS and Microflex LT. Three strains resolved 
as Corynebacterium spp. by conventional methods 
were reidentified as Actinomyces neuii, Arthrobacter 
sp., and Propionibacterium sp. Three strains 
thought to be Streptococcus spp. were reidentified as 
Actinomyces sp., Gemella morbillorum, and Weissella 
confusa. The other strains identified as Peptostrep-
Table 3. Identification Rates using MALDI-TOF MS Devices
Results by Conventional 
Identification Protocols
VITEK-MS Microflex LT








Bacillus spp.  2/47  2/47 42/47 45/47 40/47 45/47 46/47 46/47
Corynebacterium spp. 14/18 16/18 15/18 17/18 10/18 12/18 15/18 16/18
Staphylococcus spp. 8/8 8/8 8/8 8/8 5/8 6/8 6/8 7/8
Streptococcus spp. 4/5 4/5 5/5 5/5 4/5 4/5 5/5 5/5
Peptostreptococcus spp. 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1
Gram-positive rods 3/5 3/5 4/5 4/5 3/5 3/5 4/5 4/5
Gram-positive cocci 3/3 3/3 3/3 3/3 2/3 3/3 3/3 3/3
Glucose non-fermenting
Gram-negative rods  9/10  9/10 10/10 10/10  4/10 4/10  9/10 10/10
Gram-negative rods 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1
















L1R : Level 1 Reliability, meaning species-level identification
L2R : Level 2 Reliability, meaning genus-level identification
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Table 4.  Identification Discrepancies between the Conventional Protocols and MALDI-TOF MS Devices and Concor-
dance between VITEK-MS and Microflex LT
Strains VITEK-MS Microflex LT N /SubT /Total
Bacillus spp. Bacillus subtilis / 
Bacillus amyloliquefaciens (L2R) M2 Bacillus subtilis (L1R)
29 47 100
Bacillus thuringiensis / Bacillus cereus / 
Bacillus mycoides (L2R) M2
Bacillus cereus (L1R) 13
Bacillus thuringiensis (L1R) 1
Bacillus pumilus (L1R) M2 Bacillus altitudinis (L1R) 1
UNIDENTIFIED F Bacillus flexus (L1R) 1
D UNIDENTIFIED F Paenibacillus chitinolyticus (L2R) 1
D Lysinibacillus fusiformis (L1R) F UNRELIABLE IDENTIFICATION 1
Corynebacterium spp. Corynebacterium striatum (L1R) M1 Corynebacterium striatum (L1R) 4 18
Corynebacterium jeikeium (L1R) M1 Corynebacterium jeikeium (L1R) 4
Corynebacterium tuberculostearicum (L1R) M1 Corynebacterium tuberculostearicum (L1R) 1
D Actinomyces neuii (L1R) M1 Actinomyces neuii (L1R) 1
D Arthrobacter cumminsii (L1R) M2 Arthrobacter cumminsii (L2R) 2
Corynebacterium striatum (L1R) M2 Corynebacterium striatum (L2R) 1
Corynebacterium amycolatum / xerosis (L2R) M2 Corynebacterium amycolatum (L1R) 1
D Propionibacterium acnes (L1R) M2 Propionibacterium acnes (L2R) 1
UNIDENTIFIED F Corynebacterium resistens (L1R) 1
D Paenibacillus durus (L1R) F UNRELIABLE IDENTIFICATION 1
D Propionibacterium acnes (L1R) F UNRELIABLE IDENTIFICATION 1
Staphylococcus spp. Staphylococcus hominis (L1R) M1 Staphylococcus hominis (L1R) 1  8
Staphylococcus epidermidis (L1R) M1 Staphylococcus epidermidis (L1R) 1
Staphylococcus saccharolyticus (L1R) M1 Staphylococcus saccharolyticus (L1R) 1
Staphylococcus simulans (L1R) M1 Staphylococcus simulans (L1R) 1
Staphylococcus carnosus (L1R) M2 Staphylococcus condimenti (L2R) 1
Staphylococcus auricularis (L1R) M2 Staphylococcus pettenkoferi (L1R) 2
Staphylococcus simulans (L1R) F UNRELIABLE IDENTIFICATION 1
Streptococcus spp. Streptococcus gordonii (L1R) M1 Streptococcus gordonii (L1R) 1  5
D Gemella morbillorum (L1R) M1 Gemella morbillorum (L1R) 1
D Weissella confusa (L1R) M1 Weissella confusa (L1R) 1
D Actinomyces europaeus (L1R) M2 Actinomyces europaeus (L2R) 1
Streptococcus mitis / oralis (L2R) M2 Streptococcus mitis (L1R) 1




Delftia acidovorans (L1R) M1 Delftia acidovorans (L1R) 1 10
Pseudomonas oryzihabitans (L1R) M1 Pseudomonas oryzihabitans (L1R) 1
Ralstonia insidiosa (L1R) M2 Ralstonia insidiosa (L2R) 1
Acinetobacter junii (L1R) M2 Acinetobacter junii (L2R) 1
Sphingomonas paucimobilis (L1R) M2 Sphingomonas pseudosanguinis (L1R) 1
D Paenibacillus sp. (L2R) M2 Paenibacillus lautus (L2R) 1
Brevundimonas vesicularis (L1R) M2 Brevundimonas sp. (L2R) 1
Pseudomonas aeruginosa (L1R) M2 Pseudomonas nitroreducens (L1R) 1
Pseudomonas fluorescens (L1R) M2 Pseudomonas corrugata (L2R) 1
D Mycobacterium kansasii (L1R) S Herbaspirillum huttiense (L2R) 1
Gram-positive rods Propionibacterium granulosum (L1R) M1 Propionibacterium granulosum (L1R) 1  5
Lactobacillus casei / paracasei (L2R) M2 Lactobacillus paracasei (L1R) 1
UNIDENTIFIED F Bacillus flexus (L1R) 1
Propionibacterium acnes (L1R) F UNRELIABLE IDENTIFICATION 1
D Paenibacillus durus (L1R) S Mycobacterium peregrinum (L2R) 1
Gram-positive cocci Enterococcus faecalis (L1R) M1 Enterococcus faecalis (L1R) 1  3
Gemella morbillorum (L1R) M1 Gemella morbillorum (L1R) 1
Helcococcus kunzii (L1R) M1 Helcococcus kunzii (L1R) 1
Anaerobic
Gram-negative rods
Propionibacterium acnes (L1R) M1 Propionibacterium acnes (L1R) 1  2
D Streptococcus pseudopneumoniae (L1R) S Bilophila sp. (L2R) 1
Gram-negative rods Helicobacter cinaedi (L1R) M1 Helicobacter cinaedi (L1R) 1  1
N : Number of samples
SubT : Subtotal
D : Discrepant identification between conventional protocols and MALDI-TOF MS
M1 : Matched identification on bacterial species
M2 : Consistent identification at bacterial genus level
F : Unidentified with either VITEK-MS or Microflex LT
S : Inconsistently identified by VITEK-MS and Microflex LT
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tococcus sp. and Glucose non-fermenting Gram-neg-
ative rod were reidentified as Staphylococcus saccha-
rolyticus and Paenibacillus sp., respectively. Four 
strains were identified using one MALDI-TOF MS 
device, but not identified using the other (indicated 
by “F” on Table 4). The other 3 strains were dif-
ferently identified by the two MALDI-TOF MS de-
vices (indicated by “S” on Table 4).
III) Concordances and inconsistencies between the 
two MALDI-TOF MS devices
The concordance of the identification results 
between the two MALDI-TOF MS devices is also 
shown in Table 4, where the identification concor-
dance is categorized by the bacterial strains as : M1, 
matched at bacterial species (at L1R) ; M2, consis-
tent at bacterial genus (at L2R) ; F, unidentified with 
the VITEK-MS or unreliable identification by the 
Microflex LT ; or S, inconsistent identification be-
tween the VITEK-MS and Microflex LT. Between 
the two MALDI-TOF MS devices, 26% (26/100) of 
M1 concordance and 88% (88/100) of M1 and M2 
concordance was shown. The VITEK-MS failed to 
identify four bacterial strains, while the Microflex 
LT could not identify five strains (indicated by “F” 
on Table 4). Moreover, three bacterial strains were 
identified inconsistently using the VITEK-MS and 
Microflex LT (indicated by “S” on Table 4), as men-
tioned above.
IV) Confirmation of the discrepant identification re-
sults by the 16S rRNA sequencing
Of the nine strains that were reidentified using 
one MALDI-TOF MS device but not identified using 
the other, the results of four strains were inconsis-
tent with those by conventional protocols, as men-
tioned above. Therefore, 16S rRNA sequencing 
was performed additionally to confirm these discrep-
ancies, and it was verified that three of those four 
identification results using the MALDI-TOF MS de-
vices were correct (Table 5). The one other strain, 
which came out as Corynebacterium sp. through con-
ventional protocols but was reidentified as Paeniba-
cillus durus using the VITEK-MS at L1R, was still 
not resolved by 16S rRNA analysis because the nu-
cleotide sequence of this strain could not be identi-
fied by sequencing. Samples for 16S rRNA se-
quencing were taken from frozen stocks ; therefore, 
bacterial contamination or failure to preserve strains 
were considered as possible cause of this failure. 
On the other hand, the identification results of 
three strains were different between the VITEK-
MS and Microflex LT, and either identification result 
was inconsistent with that of conventional identifica-
tion protocols. One of those, thought in advance to 
be a glucose non-fermenting Gram-negative rod, 
was reidentified as Mycobacterium kansasii at L1R 
using the VITEK-MS, versus Herbaspirillum hut-
tiense at L2R using the Microflex LT. This strain 
was confirmed as Herbaspirillum sp. by 16S rRNA 
sequencing. The other strain, a Gram-positive rod 
according to conventional identification protocols, 
was resolved as Paenibacillus durus at L1R with the 
VITEK-MS, versus Mycobacterium peregrinum at 
L2R using the Microflex LT. This strain was con-
firmed as Mycolicibacterium sp., which had been cat-
egorized among Mycobacterium spp. before 2018, by 
16S rRNA sequencing. Another strain, thought to 
be an anaerobic Gram-negative rod by conventional 
methods, was identified as Streptococcus pseudopneu-
moniae with the VITEK-MS, versus Bilophila sp. 
using the Microflex LT. This strain was confirmed 
as Bilophila wadsworthia by 16S rRNA sequencing 
(Table 5).
Discussion
Blood culture is considered as the gold standard 
for diagnosis of BSIs. Immediate administration of 
effective antibiotics is essential for the appropriate 
Table 5. Confirmation by 16S rRNA Sequencing for Discrepantly Identified Bacterial Strains
Conventional Methods VITEK-MS Microflex LT 16S rRNA sequence
Bacillus spp.
Lysinibacillus fusiformis (L1R) UNRELIABLE IDENTIFICATION Lysinibacillus sp.
UNIDENTIFIED Paenibacillus chitinolyticus (L2R) Paenibacillus sp.
Corynebacterium spp.
Paenibacillus durus (L1R) UNRELIABLE IDENTIFICATION Unidentified
Propionibacterium acnes (L1R) UNRELIABLE IDENTIFICATION Propionibacterium sp.
Glucose non-fermenting
Gram-negative rods Mycobacterium kansasii (L1R) Herbaspirillum huttiense (L2R) Herbaspirillum sp.
Gram-positive rods Paenibacillus durus (L1R) Mycobacterium peregrinum (L2R) Mycolicibacterium sp.
Anaerobic Gram-negative rods Streptococcus pseudopneumoniae (L1R) Bilophila sp. (L2R) Bilophila wadsworthia
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treatment of BSIs caused by bacteria ; therefore, 
the importance of blood culture testing is supported 
by the rapid and accurate identification of the patho-
genic bacteria2). Clinical superiority of MALDI-
TOF MS devices compared to conventional morpho-
logical and biochemical identification procedures had 
been shown in previous studies, and also shown in 
the present study3-5). Both MALDI-TOF MS mod-
els, validated in our study and available in Japan, 
identified 95-96% of the tested bacterial strains at 
L1R and L2R, and resolved 49-80% of the strains at 
L1R that were not identified through conventional 
protocols. The mechanism of MALDI-TOF MS is 
to ionize sample microbes and to deduce their mate-
rial composition based on flight time. The data are 
collected worldwide and compiled into spectral data-
bases, with which homological analysis is performed 
to identify the microbes. This procedure is funda-
mentally different from conventional protocols to 
identify pathogenic bacteria, in that minute differ-
ences in the composition of each microbe can be 
recognized using MALDI-TOF MS, which operates 
independently of human senses. That is consid-
ered as the reason why MALDI-TOF MS devices 
achieve more accurate bacterial identification than 
conventional morphological and biochemical proce-
dures.
As for the sample preparation for the MALDI-
TOF MS, some of the bacterial samples were not 
well analyzed using the simple cell-smear method, a 
standard preparation for MALDI-TOF MS devices, 
whereas the additional formic acid extraction meth-
od enabled efficient analysis. This is independent 
of the models and attributed to poor ionization of the 
tested bacteria because of their cell wall structures 
and/or capsular formations. Formic acid breaks the 
bacterial cell wall, allowing proteins to be extracted, 
which has been reported to improve ionization in 
MALDI-TOF MS technology and increase its reli-
ability, as compared to the single cell-smear proce-
dure 9). If prior Gram-stain and/or colony morphol-
ogy predicts that the targeted bacterial strain has 
robust cell walls, such as yeast-like fungus or Cory-
nebacterium spp., the direct induction of the formic 
acid extraction method may improve laboratory 
throughput.
A previous study reported that genetically very 
related bacterial species, showing high homology by 
16S rRNA sequencing, were difficult to identify using 
MALDI-TOF MS devices10). In the present study, 
the concordance rates between the VITEK-MS and 
Microflex LT reached more than 90%, although each 
model yielded slightly different identification re-
sults. As an example, the candidate bacterial species 
that the VITEK-MS showed for Bacillus spp. con-
tained two or three genetically similar species, while 
the Microflex LT often showed just one species. Ac-
cording to a recent report, the VITEK-MS exhibited 
poor identification properties for differentiating 
among Bacillus cereus, Bacillus thuringiensis, and Ba-
cillus mycoides, as well as between Bacillus subtilis 
and Bacillus amyloliquefaciens11). This may be due 
to the low concordance rates at L1R with the VI-
TEK-MS ; this is supported by the current study. 
On the other hand, the identification rate at L1R for 
glucose non-fermenting Gram-negative rods result-
ed in a low profile using the Microflex LT, while that 
using the VITEK-MS resulted in a high profile. 
The Microflex LT analyzes raw spectral data of bac-
terial strains for identification, while the VITEK-MS 
utilizes data correction for bacterial identification. 
Because the principle of MALDI-TOF MS to deter-
mine the sample composition from the flight time of 
ions is the same for both models, this difference in 
analytical approaches between the two MALDI-TOF 
MS devices may affect the differing identification 
rates at L1R12,13).
The concordance rate between the two MALDI-
TOF MS models was 88% (88/100) for the bacterial 
strains identified at L1R and L2R, though nine slow-
growing bacterial strains remained unidentified using 
either model. Those bacterial strains were cultivat-
ed until visible colonies appeared, to be examined as 
target materials. Therefore, MALDI-TOF MS tech-
nology may not be as good at identification of non-
fresh strains and/or those of insufficient quantity. In 
addition, inadequate preservation of some bacterial 
strains may have contributed to their non-identifica-
tion in the present study. A recent report discussed 
unique approaches in which microorganisms con-
tained in positive blood culture bottles were directly 
identified by means of MALDI-TOF MS devices14). 
If we had been able to test fresh bacterial strains 
cultivated directly from the positive blood cultures, 
we may have been able to identify those bacterial 
strains.
Of all the strains examined in the current study, 
three strains were differently identified using the 
VITEK-MS and Microflex LT, which were confirmed 
by 16S rRNA sequencing (Table 4, 5). The three 
strains were verified to be Bilophila wadsworthia, 
Herbaspirillum sp., and Mycolicibacterium sp., re-
spectively, consistent with the results from the Mi-
croflex LT in all three cases. It has been reported 
that Mycobacterium spp. requires specialized treat-
ment before applying identification procedures15), 
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however, the Microflex LT worked without such 
specialized pre-test treatments. On the other 
hand, another strain was confirmed to be Bilophila 
wadsworthia, one of the anaerobic Gram-negative 
rods. As discussed in previous reports16,17), the data 
of anaerobic bacteria provided for MALDI-TOF MS 
analysis is still incomplete and variable, which may 
have some effect on the identification of anaerobic 
bacteria. This outcome may be a coincidence, how-
ever, since a technical difference between the two 
MALDI TOF-MS devices, namely, whether to use 
raw or processed data sets, is probably one of the 
factors, as mentioned above. Furthermore, since 
those bacterial strains are rarely detected through 
blood culture alone, further enhancement of the ref-
erence database for each MALDI-TOF MS device 
may enable more correct bacterial identification.
With regard to comparing results from conven-
tional methods with those using MALDI-TOF MS 
devices, the discrepancy rate was 15% (15/100) as 
shown in Table 4. Of those 15 strains, 53.3% (8/15) 
were identified as the same bacterial species or ge-
nus using both of the MALDI-TOF MS devices, 
which suggests that MALDI-TOF MS techniques 
could provide more beneficial information in the 
clinical settings than conventional identification pro-
tocols. Of the two tested bacterial strains that had 
been identified as Bacillus spp. through conventional 
protocols, one was reidentified as Lysinibacillus fusi-
formis using the VITEK-MS at L1R, and the other 
as Paenibacillus chitinolyticus using the Microflex LT 
at L2R, both of which were verified by 16S rRNA 
sequencing (Table 5). These bacterial species, Ly-
sinibacillus sp. and Paenibacillus sp., were classified 
as Bacillus spp. in the past, and were known as diffi-
cult species to identify through conventional proto-
cols18,19). The bacterial strains identified as Coryne-
bacterium spp. through conventional protocols were 
reidentified as Actinomyces neuii, Arthrobacter cum-
minsii, or Propionibacterium acnes by both MALDI-
TOF MS devices. These bacterial species show 
positive Gram-stainability and are classified as Co-
ryneform bacteria or Coryneform group general-
ly. It had been known that the only way to identify 
these strains was by Gram-stain, suggesting that 
there might be a limitation for the identification of 
these strains by conventional methods. The bacte-
rial strains identified as Streptococcus spp. by con-
ventional methods were reidentified as Actinomyces 
europaeus, Gemella morbillorum, or Weissella confusa 
by MALDI-TOF MS. Gemella morbillorum is clas-
sified as a Gram-positive cocci, and its morphologi-
cal features are very similar to those of Streptococcus 
spp. Gemella morbillorum was previously classified 
under the genus Streptococcus20), and was also diffi-
cult to identify using conventional protocols. Weis-
sella confusa and Actinomyces europaeus are Gram-
positive coccobacilli or coccoid rods21,22), and are also 
difficult to identify through conventional protocols 
because they form very small colonies. Peptostrep-
tococcus spp., identified using the RapID ANA II Sys-
tem with limited reliability, was reidentified as 
Staphylococcus saccharolyticus by both MALDI-TOF 
MS devices. Of the two bacterial strains identified 
as glucose non-fermenting Gram-negative rods by 
conventional methods, one was reidentified as Pae-
nibacillus sp. by both MALDI-TOF MS devices, and 
the other was reidentified as Mycobacterium kansasii 
using the VITEK-MS, versus Herbaspirillum hut-
tiense using the Microflex LT. This strain was sub-
sequently identified as Herbaspirillum sp. by 16S 
rRNA sequencing (Table 5). Paenibacillus spp. and 
Mycobacterium spp. can be either Gram negative or 
Gram positive, and often tend to be identified as glu-
cose non-fermenting Gram-negative rods using a 
MicroScan WalkAway System, though such results 
exhibit poor reliability. The strains reported as an 
anaerobic Gram-negative rod through conventional 
protocols resulted in identification discrepancies be-
tween the two MALDI-TOF MS devices, where the 
VITEK-MS identified it as Streptococcus pseudopneu-
moniae at L1R, versus the Microflex LT as Bilophila 
sp. This strain was also verified to be Bilophila 
wadsworthia by 16S rRNA sequencing. The previ-
ous studies had reported that the VITEK-MS was 
not good at identification of anaerobic bacteria23), 
which is consistent with this study.
In previous studies comparing MALDI-TOF 
MS devices, there were not such large differences 
between the bacterial identification rates of the VI-
TEK-MS (92.3-99.8%) and Microflex LT (95.5-
97.8%) at bacterial genus and species level23-25). Al-
though we used the bacterial strains whose species 
were unidentified by conventional methods, almost 
the same results were obtained in this study, which 
suggests the convenience of MALDI-TOF MS de-
vices for bacterial identification. Considering the 
results according to each bacterial species, as men-
tioned in previous studies, the VITEK-MS tended 
not to be good at identifying Bacillus spp., while the 
Microflex LT tended to be weak at identifying glu-
cose non-fermenting Gram-negative rods24-26). 
Moreover, both MALDI-TOF MS devices had been 
reported to have difficulty identifying anaerobic bac-
teria 23). 
The MALDI-TOF MS technology for the iden-
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tification of bacterial species was validated and dem-
onstrated to be easy to use and time-saving in this 
study. These features contribute to the manage-
ment of BSIs and other serious infectious diseases, 
since earlier identification of pathogenic bacteria fa-
cilitates effective treatment. As mentioned above, 
each MALDI-TOF MS model has its weaknesses 
identifying particular bacteria. In a situation where 
both the VITEK-MS and Microflex LT are available, 
the proper use of these models is considered : the 
VITEK-MS for glucose non-fermenting bacteria, 
and the Microflex LT for Gram-positive rods. 
However, few institutions or laboratories are actual-
ly equipped with both devices. Therefore, it seems 
important to utilize the MALDI-TOF MS devices 
based on the characteristics of each model. As a 
way to complement each weakness, it is recom-
mended to perform other identification methods 
such as 16S rRNA analysis in parallel. It is also 
necessary to strive to enhance the laboratory knowl-
edge and skills related to general microbiological in-
vestigations. Further accumulation of the data for 
MALDI-TOF MS analysis will help with more accu-
rate identification of pathogenic bacteria.
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